A reporter assay for G-protein-coupled receptors using a B-cell line suitable for stable episomal expression

Analytical Biochemistry
Satoshi SaekiKatsutoshi Sasaki

Abstract

We have established a cAMP response element (CRE)-mediated reporter assay system for G-protein-coupled receptors (GPCRs) using an oriP-based estrogen-inducible expression vector and the B-cell line (GBC53 or GBCC71) that expresses EBNA-1 and is adapted to serum-free culture. GBC53 harbors a GAL4-ER expression unit and a CRE-luciferase gene in the genome, and GBCC71 also harbors expression units for two chimeric Galphas proteins (Gs/q and Gs/i). Introduction of a GPCR expression plasmid into GBC53 or GBCC71 creates polyclonal stable transformants in 2 weeks, and these are easily expanded and used for assays after induction of the GPCR expression. Using GBC53, we detected ligand-dependent signals of Gs-coupled GPCRs such as glucagon-like peptide 1 receptor (GLP1R) and beta2 adrenergic receptor (beta2AR) with high sensitivity. Interestingly, we also detected constitutive activity of beta2AR. Using GBCC71, we detected ligand-dependent signals of Gq- or Gi-coupled GPCRs such as H1 histamine receptor and CXCR1 chemokine receptor in addition to Gs-coupled GPCRs. An agonist, antagonist, or inverse agonist was successfully evaluated in this system. We succeeded in constructing a 384-well high-throughput screening (HTS) system for GLP1R....Continue Reading

References

Dec 30, 1993·Biochemical and Biophysical Research Communications·M D De BackerW H Luyten
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·S BraselmannM Busslinger
Apr 22, 1999·Trends in Pharmacological Sciences·G Milligan, S Rees
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Mar 15, 2002·Drug Discovery Today·Paul A Johnston, Patricia A Johnston
Aug 9, 2002·European Journal of Pharmacology·John C AnthesRobert E Egan
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Nov 6, 2003·Journal of Biomolecular Screening·Rajasree Golla, Ramakrishna Seethala
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Alan WiseStephen Rees
Oct 20, 2005·Journal of Biomolecular Screening·Patrick M DowneyMariagrazia Grilli
Jan 13, 2006·Trends in Pharmacological Sciences·Richard A Bond, Ad P Ijzerman
Feb 8, 2007·Current Opinion in Pharmacology·Sergio Parra, Richard A Bond

❮ Previous
Next ❯

Citations

Feb 15, 2015·Analytical Biochemistry·Helle HaldMorten Meldal
Aug 23, 2020·Cells·Martin C MichelPeter Hein

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.